Phellodendrine chloride
CAS No. 104112-82-5
Phellodendrine chloride ( Phellodendrine chloride; l-(-)-N-Methylcoreximine )
产品货号. M17774 CAS No. 104112-82-5
Phellodendrine chloride has anti-nephritic activity, may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥1235 | 有现货 |
|
25MG | ¥2117 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Phellodendrine chloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Phellodendrine chloride has anti-nephritic activity, may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.
-
产品描述Phellodendrine Chloride is an alkaloid isolated from the Phellodrndron amurensis, which shows activity as an immunosuppressor against the cellular immune response.
-
同义词Phellodendrine chloride; l-(-)-N-Methylcoreximine
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number104112-82-5
-
分子量377.86
-
分子式C20H24ClNO4
-
纯度98%
-
溶解度——
-
SMILES[Cl-].COc2cc3C[N+]4(C)CCc1cc(OC)c(O)cc1[C@@H]4Cc3cc2O
-
化学全称(13aS)-2,11-dihydroxy-3,10-dimethoxy-7-methyl-5,6,7,8,13,13a-hexahydroisoquinolino[3,2-a]isoquinolin-7-ium chloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yin F, et al.DECOCTION PROCESS OPTIMIZATION AND QUALITY EVALUATION OF YI-HUANG DECOCTION BY HPLC FINGERPRINT ANALYSIS.Acta Pol Pharm. 2016 Jul;73(4):855-864.
产品手册
关联产品
-
RNPA1000
RNPA1000 is a potent, specific small molecule inhibitor of S. aureus RnpA RNA degradation activity (IC50=100-125 uM).
-
Nevadensin
Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1 (hCE1) with an IC50 of 2.64 μM. Nevadensin has a variety of pharmacological effects such as anti-mycobacterium tuberculosis activities, antitussive, anti-inflammatory and anti-hypertensive.
-
Doripenem
Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.